Perceptive Advisors’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-501,509
| Closed | -$23.1M | – | 125 |
|
|
2022
Q1 | $23.1M | Buy |
501,509
+70,965
| +16% | +$3.27M | 0.46% | 51 |
|
|
2021
Q4 | $36.2M | Buy |
+430,544
| New | +$36.2M | 0.56% | 47 |
|
|
2021
Q1 | – | Sell |
-1,050,003
| Closed | -$54.5M | – | 164 |
|
|
2020
Q4 | $54.5M | Hold |
1,050,003
| – | – | 0.59% | 41 |
|
|
2020
Q3 | $34.3M | Hold |
1,050,003
| – | – | 0.5% | 53 |
|
|
2020
Q2 | $45.8M | Buy |
+1,050,003
| New | +$45.8M | 0.74% | 35 |
|